Lorenza Pistola

Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer

Vienna Ludovini, Fortunato Bianconi, Lorenza Pistola et al. · Journal of Thoracic Oncology · 2011 · 176 citations · Full text

Kras Mutations, Medicine, Receptor Tyrosine Kinase +8

Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival

Vienna Ludovini, Stefania Gori, Mariantonietta Colozza et al. · Annals of Oncology · 2008 · 116 citations · Full text

Breast Oncology, Oncology, Medicine +7

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients

Vienna Ludovini, Guido Bellezza, Lorenza Pistola et al. · Annals of Oncology · 2009 · 114 citations

Medicine, Pathology, Bronchial Neoplasm +7

Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients

V. Ludovini, Angelo Sidoni, Lorenza Pistola et al. · Breast Cancer Research and Treatment · 2003 · 99 citations

Breast Oncology, Angiogenesis, Microvessel Density +10

Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients: A Study of the Perugia Multidisciplinary Team for Thoracic Oncology

Vienna Ludovini, Lorenza Pistola, Vanesa Gregorc et al. · Journal of Thoracic Oncology · 2008 · 76 citations · Full text

Plasma Dna, Perugia Multidisciplinary Team, Medicine +8